SavedAdd your journal

Journals / Acta Medica Alanya / 2021 / Cilt: 5 Sayı: 3

Transcranial Magnetic stimulation in Neurodegenerative Diseases: Basics and Clinical Applications

Nörodejeneratif Hastalıklarda Transkraniyal Manyetik Uyarım: Temeller ve Klinik Uygulamalar

Burak Yuluğ(ALANYA ALAADDIN KEYKUBAT UNIVERSITY)0000-0002-9704-6173
Ahmet Aslan(Alanya Alaaddin Keykubat Üniversitesi, Tıp Fakültesi)0000-0001-5797-1287
Pages
216–217
Publication Date
2021-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this letter, we evaluate the role of rTMS on the network neuroplasticity and neuroprotective pathways, including especially the Brain-Derived Neurotrophic Factor (BDNF), which mediates the pro-cognitive and neuroprotective effects of rTMs, suggesting that rTMS is a potential neuroprotective and pro-cognitive therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Transcranial Magnetic Stimulation (rTMS) non-invasively modulates brain networks via stimulating relevant brain regions responsible for motor and cognitive functions.
📊
Key Findings & Data:However, replicating human and animal data suggests the therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in many neurological diseases.
💡
Conclusion & Impact:In this letter, we evaluate the role of rTMS on the network neuroplasticity and neuroprotective pathways, including especially the Brain-Derived Neurotrophic Factor (BDNF), which mediates the pro-cognitive and neuroprotective effects of rTMs, suggesting that rTMS is a potential neuroprotective and pro-cognitive therapy.
🔬Design:Editoryal
📍Scope:Comprehensive Sample
⚙️Variables:Transkraniyal Manyetik Uyarım · Nöroproteksiyon · Nörolojik Hastalıklar

Abstract

Transcranial Magnetic Stimulation (rTMS) non-invasively modulates brain networks via stimulating relevant brain regions responsible for motor and cognitive functions. However, replicating human and animal data suggests the therapeutic role of repetitive transcranial magnetic stimulation (rTMS) in many neurological diseases. In this letter, we evaluate the role of rTMS on the network neuroplasticity and neuroprotective pathways, including especially the Brain-Derived Neurotrophic Factor (BDNF), which mediates the pro-cognitive and neuroprotective effects of rTMs, suggesting that rTMS is a potential neuroprotective and pro-cognitive therapy.

Özet

Transkraniyal Manyetik Stimülasyon (rTMS), motor ve bilişsel işlevlerden sorumlu ilgili beyin bölgelerini uyararak beyin ağlarını non-invaziv olarak modüle eder. Bununla birlikte, insan ve hayvan verilerinin kopyalanması, birçok nörolojik hastalıkta tekrarlayan transkraniyal manyetik stimülasyonun (rTMS) terapötik rolünü ortaya koymaktadır. Bu yazıda, özellikle rTM'lerin bilişsel ve nöroprotektif etkilerine aracılık eden Beyinden Türetilmiş Nörotrofik Faktör (BDNF) dahil olmak üzere, rTMS'nin ağ nöroplastisitesi ve nöroprotektif yolaklar üzerindeki rolünü gözden geçirdik. BDNF rTM'lerin bilişsel ve nöroprotektif etkileri, rTMS'nin potansiyel bir nöroprotektif ve pro-bilişsel terapi olduğunu düşündürmektedir.

🔖

Cite This Article

Yuluğ, B., Aslan, A. (2021). Transcranial Magnetic stimulation in Neurodegenerative Diseases: Basics and Clinical Applications. Acta Medica Alanya, Cilt: 5 Sayı: 3, 216–217. https://doi.org/10.30565/medalanya.1035797

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Eschweiler G.W. (2003) Entwicklung der transkraniellen Magnetstimulation (TMS). In: Eschweiler G.W., Wild B., Bartels M. (eds) Elektromagnetische Therapien in der Psychiatrie. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57370-5_16
  2. Yulug B. Neuroprotective treatment strategies for poststroke mood disorders: A minireview on atypical neuroleptic drugs and selective serotonin re-uptake inhibitors. Brain Res Bull. 2009 Sep 28;80(3):95-9. doi: 10.1016/j.brainresbull.2009.06.013. Epub 2009 Jul 1. PMID: 19576272.
  3. Caglayan B, Kilic E, Dalay A, et al. Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in mice. Mol Biol Rep. 2019;46(1):241-250. doi:10.1007/s11033-018-4465-4
  4. Lapchak, Paul A., and John H. Zhang, eds. Neuroprotective therapy for stroke and ischemic disease. Switzerland: Springer International Publishing, 2017. doi:10.1007/978-3-319-45345-3
  5. Hanoglu L, Velioglu HA, Hanoglu T, Yulug B. Neuroimaging-Guided Transcranial Magnetic and Direct Current Stimulation in MCI: Toward an Individual, Effective and Disease-Modifying Treatment [published online ahead of print, 2021 Nov 9]. Clin EEG Neurosci. 2021;15500594211052815. doi:10.1177/15500594211052815
  6. Yulug B, Hanoglu L, Tavli AM, Yılmaz NH, Kılıc E. The Brain Protective Effect of rTMS (Repetitive Transcranial Magnetic Stimulation) in Depression: A Mini-Review in Animal Studies. Med Chem. 2016;12(6):500-505. doi:10.2174/1573406411666151005110321
  7. Yuluğ B, Ozan E, Kilic E. Brain-derived neurotrophic factor polymorphism as a genetic risk for depression? A short review of the literature. J Neuropsychiatry Clin Neurosci. 2010 Winter;22(1):123.E5-6. doi: 10.1176/jnp.2010.22.1.123.e5
  8. Yulug B, Hanoglu L, Khanmammadov E, et al. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF?: A Minireview. Mini Rev Med Chem. 2018;18(17):1479-1485. doi:10.2174/1389557517666170927162537
  9. Velioglu HA, Hanoglu L, Bayraktaroglu Z, et al. Left lateral parietal rTMS improves cognition and modulates resting brain connectivity in patients with Alzheimer's disease: Possible role of BDNF and oxidative stress. Neurobiol Learn Mem. 2021;180:107410. doi:10.1016/j.nlm.2021.107410
  10. Saricaoglu M, Hanoglu L, Toprak G, Yilmaz NH, Yulug B. The Multifactorial Role of Pre-supplementary Motor Area Stimulation in the Freezing of Gait: An Alternative Strategy to the Classical Drug-Target Approach [published online ahead of print, 2021 Oct 14]. Endocr Metab Immune Disord Drug Targets. 2021;10.2174/1871530321666211014170107. doi:10.2174/1871530321666211014170107
  11. Yulug B, Hanoglu L, Khanmammadov E, et al. Beyond The Therapeutic Effect of rTMS in Alzheimer's Disease: A Possible Neuroprotective Role of Hippocampal BDNF?: A Minireview. Mini Rev Med Chem. 2018;18(17):1479-1485. doi:10.2174/1389557517666170927162537